The Japanese company Ushio says that it will sell the Care 222 UV lamp to medical facilities first for about $2,800 a piece. The company also foresees the lamps being used on buses, trains, elevators, and offices.
As reported in Infection Control Today® recently, ultraviolet (UV) light holds great potential as a disinfectant in general, and as a way to stop the spread of coronavirus disease 2019 (COVID-19) in particular. However, it can be tricky to use. Well, a Japanese company called Ushio thinks it might have found a way around one of the problems with UV disinfection. The company says it has developed a UV lamp that disinfects rooms even when there are people present. The product, called the Care 222 UV lamp, emits a UV wavelength of 220 nanometers. The company developed the lamp with the help of scientists at Columbia University.
Conventional UV lamps up until now have emitted a wavelength of 254 nanometers, which can harm people, penetrating skin and eyes and possibly causing genetic defects. “Thus, the germicidal lamp UV disinfection systems can mainly only be used in unoccupied spaces,” says a study in the American Journal of Infection Control (AJIC) by investigators with Hiroshima University Hospital that helped pave the way for the manufacturing of the CARE 222 UV lamp.
Ushio says that it will sell the lamp to medical facilities first. “To protect healthcare workers and to help stop the spread of SARS-CoV-2, more thorough prevention and control practices are needed,” the AJIC study states. “Since COVID-19 has become a pandemic and there are asymptomatic patients, attention is being focused on environmental disinfection in public spaces beyond healthcare settings in which many people come into contact with various surfaces.” However, the company foresees the lamps eventually being used far and wide—in buses, trains, elevators, and offices.
As reported in the online newspaper Japan Today, the Care 222 UV lamp would be installed in ceilings. When it emits the UV light, it kills 99.7% of viruses and bacteria in the air and on surfaces of objects within 8 feet of the lamp. The application takes between 6 and 8 minutes.
The device weighs 2.6 pounds and the company plans to sell them for around $2,800 a piece.
In a press release, Ushio notes that “it is important to use filtered 222nm UV-C light in occupied spaces. Unfiltered 222nm UV-C lamps will emit radiation in the 230nm (UV-C) to 320nm (UV-B) range. Irradiation without blocking these higher wavelengths of light has been reported to cause erythema and damage to the cellular DNA at considerably lower levels than filtered 222nm light.”
The AJIC study notes that “SARS-CoV-2 is mainly transmitted through infected respiratory droplets and close contact with infected people. Recent studies showed that SARS-CoV-2 can remain viable for days on surfaces under controlled experimental conditions. Furthermore, surfaces in hospitals treating patients with COVID-19 were found to be contaminated by SARS-CoV-2, suggesting that the hospital environment could be a potential medium of transmission. Therefore, if environmental disinfection is not effective, SARS-CoV-2 may spread widely and cause nosocomial infections.”
“Ongoing Assault”: How HHS Layoffs Have Eviscerated Infection Prevention Support Across the Nation
April 1st 2025Mass layoffs at HHS and CDC have gutted critical infection prevention programs, leaving frontline professionals overwhelmed, under-resourced, and desperate to safeguard public health.
Vet IP Roundtable 2: Infection Control and Biosecurity Challenges in Veterinary Care
March 31st 2025Veterinary IPs highlight critical gaps in cleaning protocols, training, and biosecurity, stressing the urgent need for standardized, animal-specific infection prevention practices across diverse care settings.
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.